Hepatocellular Carcinoma Mortality Rates Rising in the US, Driven by Alcohol and Metabolic Liver Dis | Docwire News
Rising HCC mortality rates in the US highlight stark disparities across age, sex, race, and liver disease etiologies.
Related Articles
‎Healthcare Unfiltered: From Apartheid to Abraxane: Dr. Soon-Shiong on Medicine, Entrepreneurship, Business, and Triumph on Apple Podcasts
‎Show Healthcare Unfiltered, Ep From Apartheid to Abraxane: Dr. Soon-Shiong on Medicine, Entrepreneurship, Business, and Triumph – Jul 16, 2024
From Apartheid to Abraxane: Dr. Soon-Shiong on Medicine, Entrepreneurship, Business, and Triumph
In this exclusive interview on Healthcare Unfiltered, I welcome Dr. Patrick Soon-Shiong, a Chinese immigrant who grew up under apartheid in South Africa and …
IWG 2023, 2006 MDS Criteria Assessments of Ivosidenib for mIDH1 Disease Compared | Docwire News
Researchers argue from their findings that the 2023 criteria more accurately present the performance of ivosidenib in MDS.
Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden:
AbstractBackgroundLower air temperature and cold spells have been associated with an increased risk of various diseases. However, the short-term effect of lower air temperature and…
Development of Patient-Derived Lymphoma Tumoroids for Studying Follicular Lymphoma | Blood Cancers Today
Follicular lymphoma demonstrates a strong interplay with its tumor microenvironment, influencing disease progression and therapy resistance.
Episode 39. ASH 2023 Leukemia and Myeloid Neoplasm Recap with Dr. Anand Patel | Blood Cancer Talks | Episode 39
In this episode, we discuss top abstracts in the myeloid space from the American Society of Hematology 2023 meeting with Dr. Anand Patel. Here are the…
Episode 40. Management of Newly Diagnosed AL Amyloidosis | Blood Cancer Talks | Episode 41
In this episode we discuss the management of newly diagnosed AL amyloidosis with Dr. Angela Dispenzieri from the Mayo Clinic. Here are the key articles discussed:1. …
Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach | Blood Cancer Talks | Episode 54
In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at…
Episode 42. CAR T-cell Therapy in Early Relapsed Myeloma with Dr. Samer Al Hadidi | Blood Cancer Talks | Episode 43
In this episode, we talked about overall survival data from CARTITUDE-4 and KarMMa-3 that was presented at FDA ODAC meeting with Dr. Samer Al Hadidi…
Episode 51. Venetoclax in AML with Dr. Andrew Wei | Blood Cancer Talks | Episode 52
In this episode, we discuss the history of venetoclax in AML, along with key clinical trials that have shaped its current use in AML. Here…